Founded in 1916, it is a famous trademark in Shanghai, and an earlier enterprise mainly engaged in the research and development, manufacturing and sales of national chemicals

Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd. is a direct subsidiary of Shanghai Pharmaceutical. Founded in 1916, Xinyi brand is one of the earliest national chemical and pharmaceutical enterprises in modern China. After a hundred years of inheritance, it has continued to grow and develop, and has become a large-scale national pharmaceutical enterprise integrating manufacturing, sales and research and development. Xinyi has a strong channel and terminal coverage capabilities, and its marketing network radiates to more than 30 provinces, municipalities and autonomous regions across the country, covering nearly 10,000 hospital terminals, more than 800 major distributors, more than 150 prefecture-level cities, and has a high-quality and professional terminal sales team of more than 1,200 people.

Xinyi is an industrial entity with many products and complete dosage forms of chemical and pharmaceutical enterprises in China, with 1,114 product approvals, involving 14 therapeutic fields, covering 16 dosage forms, and 3 national first-class new drug varieties, among which "Peifeikang" is a national first-class biological product, which has obtained patents in China, the United States, the United Kingdom, Canada, Australia and other countries. In 2012, "Peifeikang" was selected as the "National Standard Strain" of probiotic preparations, and is currently being registered with the US FDA as a product with independent intellectual property rights. On the basis of maintaining the leading position of prescription drugs, the company will enter the OTC format with "Peifeikang" as its main product, and will make unremitting efforts in the next few years to make it one of the largest enterprises in China's pharmaceutical industry, and always become a pioneer in the development of the microecological field.